Skip to main content

Table 1 Clinical characteristics between CAD and control groups

From: Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study

CharacteristicsCAD (n = 580)Control (n = 437)P
Age (year), mean (SD)64.16 ± 9.9361.26 ± 9.35< 0.001
Gender, male (%)410 (70.69)227 (51.95)< 0.001
EH, n (%)420 (72.41)254 (58.12)< 0.001
DM, n (%)148 (25.52)61 (13.96)< 0.001
Smoking, n (%)223 (38.44)109 (24.94)< 0.001
TC (mmol/l), mean (SD)4.60 ± 1.064.43 ± 0.950.012
TG (mmol/l), mean (SD)1.47(1.06–2.10)1.36(0.96–2.02)0.032
HDL-C (mmol/l), mean (SD)1.08 ± 0.271.17 ± 0.31< 0.001
LDL-C (mmol/l), mean (SD)2.96 ± 0.952.66 ± 0.80< 0.001
ApoA1 (g/L), mean (SD)1.18 ± 0.221.24 ± 0.24< 0.001
ApoB (g/L), mean (SD)0.97 ± 0.290.91 ± 0.26< 0.001
  1. CAD Coronary artery disease, TC Total cholesterol, TG Triglyceride, HDL-C High density lipoprotein cholesterol, LDL-C Low density lipoprotein cholesterol, Apo Apolipoprotein, EH Essential hypertension, DM Diabetes mellitus, SD Standard deviation